PB1761: PRECLINICAL EVALUATION OF THE MENIN INHIBITOR ZIFTOMENIB IN PRIMARY AML SPECIMENS by Brett Stevens, Krysta Engel, Austin Gillen, Shanshan Pei, Anna Krug, Monica Ransom, Sarah Staggs, Francis Burrows, Blake Tomkinson, Linda Kessler, Craig Jordan, Clayton Smith

Get full text

Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with <i>MLL</i> rearrangement or <i>NPM1... by Johanna Rausch, Margarita M. Dzama, Nadezda Dolgikh, Hanna L. Stiller, Stephan R. Bohl, Catharina Lahrmann, Kerstin Kunz, Linda Kessler, Hakim Echchannaoui, Chun-Wei Chen, Thomas Kindler, Konstanze Döhner, Francis Burrows, Matthias Theobald, Daniel Sasca, Michael W.M. Kühn

Get full text

Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies by Sarah Figarol, Célia Delahaye, Rémi Gence, Aurélia Doussine, Juan Pablo Cerapio, Mathylda Brachais, Claudine Tardy, Nicolas Béry, Raghda Asslan, Jacques Colinge, Jean-Philippe Villemin, Antonio Maraver, Irene Ferrer, Luis Paz-Ares, Linda Kessler, Francis Burrows, Isabelle Lajoie-Mazenc, Vincent Dongay, Clara Morin, Amélie Florent, Sandra Pagano, Estelle Taranchon-Clermont, Anne Casanova, Anne Pradines, Julien Mazieres, Gilles Favre, Olivier Calvayrac

Get full text